Literature DB >> 7542783

Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.

M C Maa1, T H Leu, D J McCarley, R C Schatzman, S J Parsons.   

Abstract

c-Src is a nontransforming tyrosine kinase that participates in signaling events mediated by a variety of polypeptide growth factor receptors, including the epidermal growth factor receptor (EGFR). Overexpression and continual ligand stimulation of the EGFR results in morphological transformation of cells in vitro and tumor development in vivo. Elevated levels of c-Src and the EGFR are found in a variety of human malignancies, raising the question of whether c-Src can functionally cooperate with the EGFR during tumorigenesis. To address this issue, we generated c-Src/EGFR double overexpressors and compared their proliferative and biochemical characteristics to those of single overexpressors and control cells. We found that in cells expressing high levels of receptor, c-Src potentiated DNA synthesis, growth in soft agar, and tumor formation in nude mice. Growth potentiation was associated with the formation of a heterocomplex between c-Src and activated EGFR, the appearance of a distinct tyrosyl phosphorylation on the receptor, and an enhancement of receptor substrate phosphorylation. These findings indicate that c-Src is capable of potentiating receptor-mediated tumorigenesis and suggest that synergism between c-Src and the EGFR may contribute to a more aggressive phenotype in multiple human tumors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542783      PMCID: PMC41455          DOI: 10.1073/pnas.92.15.6981

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate.

Authors:  M C Maa; L K Wilson; J S Moyers; R R Vines; J T Parsons; S J Parsons
Journal:  Oncogene       Date:  1992-12       Impact factor: 9.867

2.  Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors.

Authors:  J H Chang; L K Wilson; J S Moyers; K Zhang; S J Parsons
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

3.  The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors.

Authors:  P Martin; W C Vass; J T Schiller; D R Lowy; T J Velu
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

4.  A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor.

Authors:  M F White; S E Shoelson; H Keutmann; C R Kahn
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

5.  Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.

Authors:  C T Guy; S K Muthuswamy; R D Cardiff; P Soriano; W J Muller
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

6.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

Authors:  P P Di Fiore; J H Pierce; T P Fleming; R Hazan; A Ullrich; C R King; J Schlessinger; S A Aaronson
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

7.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Authors:  T J Velu; L Beguinot; W C Vass; M C Willingham; G T Merlino; I Pastan; D R Lowy
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

8.  c phosphorylation and activation of the IGF-I receptor in src-transformed cells.

Authors:  J E Peterson; T Jelinek; M Kaleko; K Siddle; M J Weber
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

9.  Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor.

Authors:  S A Courtneidge; R Dhand; D Pilat; G M Twamley; M D Waterfield; M F Roussel
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

10.  Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex.

Authors:  H Wu; J T Parsons
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

View more
  97 in total

Review 1.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

2.  The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Authors:  Ying Dong; Yaowu He; Leonore de Boer; M Sharon Stack; John W Lumley; Judith A Clements; John D Hooper
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines.

Authors:  Jie Zhang; Shailaja Kalyankrishna; Marie Wislez; Nishan Thilaganathan; Babita Saigal; Wei Wei; Long Ma; Ignacio I Wistuba; Faye M Johnson; Jonathan M Kurie
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.

Authors:  Priya Koppikar; Seung-Ho Choi; Ann Marie Egloff; Quan Cai; Shinsuke Suzuki; Maria Freilino; Hiroshi Nozawa; Sufi M Thomas; William E Gooding; Jill M Siegfried; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

5.  Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.

Authors:  Hiroshi Nozawa; Gina Howell; Shinsuke Suzuki; Qing Zhang; Yanjun Qi; Judith Klein-Seetharaman; Alan Wells; Jennifer R Grandis; Sufi M Thomas
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

Review 6.  Arsenic carcinogenicity: relevance of c-Src activation.

Authors:  Petia P Simeonova; Michael I Luster
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.

Authors:  D A Tice; J S Biscardi; A L Nickles; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 8.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.

Authors:  Kelly L Mueller; Lauren A Hunter; Stephen P Ethier; Julie L Boerner
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

10.  EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK.

Authors:  Kelly L Mueller; Katelyn Powell; Julie M Madden; Scott T Eblen; Julie L Boerner
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.